Adam Vogel
Stock Analyst at Craig-Hallum
(3.21)
# 2,504
Out of 5,051 analysts
34
Total ratings
48.5%
Success rate
7.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Adam Vogel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: MSCL Satellos Bioscience Inc. | Initiated Coverage: Buy | $34.21 | $10.71 | +219.43% | 1 | Oct 8, 2026 | |
| ATHE Alterity Therapeutics | Rated: Buy | $12 → $15 | $2.93 | +411.95% | 2 | Oct 5, 2026 | |
| IMNM Immunome | Reiterated: Buy | $36 | $19.15 | +87.99% | 9 | Aug 12, 2026 | |
| LBRX LB Pharmaceuticals | Reiterated: Buy | $36 → $45 | $35.93 | +25.24% | 5 | Aug 12, 2026 | |
| ACRS Aclaris Therapeutics | Reiterated: Buy | $10 | $3.60 | +177.78% | 6 | Aug 6, 2026 | |
| PEPG PepGen | Reiterated: Buy | $11 | $2.49 | +341.77% | 2 | Aug 6, 2026 | |
| DSGN Design Therapeutics | Reiterated: Buy | $22 | $10.91 | +101.65% | 5 | Aug 4, 2026 | |
| MPLT MapLight Therapeutics | Reiterated: Buy | $40 → $25 | $8.60 | +190.70% | 3 | Jul 28, 2026 | |
| HIT Health In Tech | Reiterated: Buy | n/a | $0.7201 | - | 1 | Apr 10, 2026 |
Satellos Bioscience Inc.
Oct 8, 2026
Initiated Coverage: Buy
Price Target: $34.21
Current: $10.71
Upside: +219.43%
Alterity Therapeutics
Oct 5, 2026
Rated: Buy
Price Target: $12 → $15
Current: $2.93
Upside: +411.95%
Immunome
Aug 12, 2026
Reiterated: Buy
Price Target: $36
Current: $19.15
Upside: +87.99%
LB Pharmaceuticals
Aug 12, 2026
Reiterated: Buy
Price Target: $36 → $45
Current: $35.93
Upside: +25.24%
Aclaris Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $10
Current: $3.60
Upside: +177.78%
PepGen
Aug 6, 2026
Reiterated: Buy
Price Target: $11
Current: $2.49
Upside: +341.77%
Design Therapeutics
Aug 4, 2026
Reiterated: Buy
Price Target: $22
Current: $10.91
Upside: +101.65%
MapLight Therapeutics
Jul 28, 2026
Reiterated: Buy
Price Target: $40 → $25
Current: $8.60
Upside: +190.70%
Health In Tech
Apr 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.7201
Upside: -